These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10772604)

  • 1. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
    Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
    J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
    Baltieri DA; Daró FR; Ribeiro PL; Andrade AG
    Drug Alcohol Depend; 2009 Nov; 105(1-2):33-41. PubMed ID: 19595518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone in the treatment of alcohol dependence.
    Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA;
    N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS; Rounsaville BJ; Farren C; Namkoong K; Wu R; Robinson J; O'Connor PG
    Arch Intern Med; 2003 Jul; 163(14):1695-704. PubMed ID: 12885685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
    Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
    Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of compliance with naltrexone among alcoholics.
    Rohsenow DJ; Colby SM; Monti PM; Swift RM; Martin RA; Mueller TI; Gordon A; Eaton CA
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1542-9. PubMed ID: 11045863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
    Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G
    Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse.
    O'Malley SS
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():77-81. PubMed ID: 8737005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
    Colagiuri B; Morley K; Boakes R; Haber P
    Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.